GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Function of TbRIII as a BMP Co-receptor in Human Cancer

$327,279
Gerard C Blobe · Duke University · R01 · FY2013 · CA

Integration of stromal targeting agents with immune checkpoint therapy

$327,273
Lei Zheng · Johns Hopkins University · P01 · FY2024 · CA

Role of Glypican-1 in Pancreatic Cancer

$327,233
University Of California Irvine · R01 · FY2003 · CA

Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines

$327,201
Valery A Petrenko · Northeastern University · U54 · FY2010 · CA

Stroma Targeted Theranostic Nanoparticles for Pancreatic Cancer

$327,188
Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · CA

Stroma Targeted Theranostic Nanoparticles for Pancreatic Cancer

$327,188
Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · CA

Leukocyte-Endothelial Adhesion in Tumor Immunity

$327,181
Roswell Park Cancer Institute Corp · R01 · FY2004 · CA

Project 1- Role of fat in metastatic engraftment and expansion in the liver

$327,163
Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2021 · CA

Ribonucleases in Cancer Chemotherapy

$327,117
Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2015 · CA

Ribonucleases in Cancer Chemotherapy

$327,117
Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2014 · CA

Ribonucleases in Cancer Chemotherapy

$327,117
Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2016 · CA

HORMONES: BIOCHEMISTRY AND MOLECULAR BIOLOGY

$327,077
Max Elliot Gottesman · Columbia University Health Sciences · T32 · FY2013 · DK

Cost and Quality of Cancer Surgery

$327,050
Vivian Ho · Rice University · R01 · FY2010 · CA

Gq-Coupled Receptors Inhibit PI 3-Kinase/Akt Signaling Pathway

$326,985
Richard Z Lin · State University New York Stony Brook · R01 · FY2011 · DK

Gq-Coupled Receptors Inhibit PI 3-Kinase/Akt Signaling Pathway

$326,985
Richard Z Lin · State University New York Stony Brook · R01 · FY2012 · DK

Tailoring New Drugs in Pancreatic Cancer

$326,952
Manuel Hidalgo · Johns Hopkins University · R01 · FY2007 · CA

Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy

$326,903
Weiqin Lu · University Of Texas El Paso · R01 · FY2024 · CA

Hedgehog Pathway Blockade by Small-Molecule Gli Antagonists

$326,885
James K Chen · Stanford University · R01 · FY2012 · CA

The RAS and P13K Pathways in Pancreatic Adenocarcinoma

$326,760
Lewis C Cantley · Dana-Farber Cancer Inst · P01 · FY2006 · CA

Hedgehog Pathway Blockade by Small-Molecule Gli Antagonists

$326,699
James K Chen · Stanford University · R01 · FY2011 · CA

Regulation of exocrine pancreas formation

$326,658
Lori Sussel · Columbia University Health Sciences · R01 · FY2012 · DK

Discovery and Development of Cancer Glycomarkers

$326,634
James Michael Pierce · University Of Georgia · U01 · FY2013 · CA

Dysregulation of TGF Beta Action Pancreatic Cancer

$326,487
University Of California Irvine · R01 · FY2002 · CA

Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis

$326,417
Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2013 · CA

Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy

$326,319
Ke Sheng · University Of California Los Angeles · R01 · FY2019 · CA